# Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of ‘deep’ product reviews

> Research article (Health Research Policy and Systems, 2017) · cited 12× · AI/ML

**Wikidata**: [openalex:W2763271076](https://www.wikidata.org/wiki/openalex:W2763271076)  
**Source**: https://4ort.xyz/entity/why-european-and-united-states-drug-regulators-are-not-speaking-with-one-voice-on-anti-influenza-drugs-regulatory-review